Transcenta Reveals Hopeful Cancer Drug Trial Results
Transcenta Holding Limited (HK:6628) has released an update. Transcenta Holding Limited has reported promising Phase II results for Osemitamab (TST...
Source: biztoc.com
Transcenta Holding News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Transcenta Holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Transcenta Holding Today - Breaking & Trending Today
Transcenta Unveils Updated Efficacy Data from Osemitamab (TST001) Plus CAPOX as First-Line Treatment for G/GEJ Cancer Study at ESMO 2023
Latest data reveals a 55% confirmed response rate, median duration of response (DoR) and median progression-free survival (PFS) of more than 12 months for all
Source: thailand-business-news.com
FDA Grants Transcenta Clearance to Proceed with Global Phase III Trial of Osemitamab (TST001) as First-Line Treatment for Gastric/Gastroesophageal Cancer Patients
/PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in...
Source: prnewswire.com
Global Claudin 18.2-Targeted Immunotherapy Landscape
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Global Claudin 18.2-Targeted Immunotherapy Landscape Analysis Report 2023: Potential Approvals and Market Launches Expected During the Course of 2024
/PRNewswire/ -- The "Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An...
Source: prnewswire.com